News Focus
News Focus
icon url

purpledawgs

08/19/18 1:57 PM

#328121 RE: geocappy1 #328120

Geo:

Based on the purchase-sale agreement it is any of the following:

“Seller Therapy” means Seller’s proprietary bavituximab antibody therapy and Seller’s fully human PS-targeting antibodies.

https://www.sec.gov/Archives/edgar/data/704562/000168316818001961/avid_ex1011.htm

PD
icon url

The Other Guy

08/19/18 4:17 PM

#328123 RE: geocappy1 #328120

Other than on this forum, has betabodies ever been touted as being anything special. It just feels like propaganda from the old regime.
icon url

Threes

08/19/18 9:21 PM

#328126 RE: geocappy1 #328120

What about the 95 MM in milestone payments, the direct cost of Bavi/ BB's both in the many trials I hope we will see started. And if successful royalties in the teens along with increased sales of Bavi to the approved vendor.. Is the current BOD savy where the last was not. Do these guys know how to ring the bell. They have plenty of shares and options. People would make serious money and we retail could well be aligned with them. Everyone is greedy. They will know how the trials are going better than anyone. They will see the volume of Bavi going out. Could get interesting. Remember the trials will be listed on clinical trials .gov.